Donor selection procedures: is it possible to improve them?

[1]  L. Eldred,et al.  Evaluation of HIV case surveillance through the use of non-name unique identifiers--Maryland and Texas, 1994-1996. , 1998, MMWR. Morbidity and mortality weekly report.

[2]  A. Grindon,et al.  Assessment of motivations for return donation among deferred blood donors. American Red Cross ARCNET Study Group , 1998, Transfusion.

[3]  S. Kleinman,et al.  The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. , 1997, Transfusion medicine reviews.

[4]  G A Satten,et al.  Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. , 1997, The American journal of medicine.

[5]  R. Aster,et al.  Paid time off for blood donation—an incentive to be less than truthful? , 1997, Transfusion.

[6]  A. Williams,et al.  Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. , 1997, JAMA.

[7]  R. Westphal.  Donors and the United States blood supply , 1997, Transfusion.

[8]  W. M. Rabinowitz,et al.  Assessment of blood donor privacy during health history interviews , 1996, Transfusion.

[9]  A. Williams,et al.  Demographic determinants of hepatitis C virus seroprevalence among blood donors. , 1996, JAMA.

[10]  L. Petz,et al.  Clinical Practice of Transfusion Medicine , 1995 .

[11]  A. Williams,et al.  Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study , 1994, Transfusion.

[12]  R. Dodd,et al.  The effectiveness of the confidential unit exclusion option , 1994, Transfusion.

[13]  Michael John Smith,et al.  Concurrent comparison of the safety of paid cytapheresis and volunteer whole‐blood donors , 1994, Transfusion.

[14]  D. Huestis,et al.  Donors and dollars , 1994, Transfusion.

[15]  L. Doll,et al.  Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors , 1993, Transfusion.

[16]  L. Kirchhoff,et al.  Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi , 1993, Transfusion.

[17]  D. Mayo.  Evaluating donor recruitment strategies , 1992, Transfusion.

[18]  J. Jackson.  Human immunodeficiency virus (HIV)‐indeterminate western blots and latent HIV infection , 1992, Transfusion.

[19]  M. Sayers.  Duties to donors , 1992, Transfusion.

[20]  L. Friedman,et al.  Effects of oral donor questioning about high‐risk behaviors for human immunodeficiency virus infection , 1992, Transfusion.

[21]  S. Maclennan,et al.  Screening blood donations for HCV , 1992, The Lancet.

[22]  C Safran,et al.  Computer-based interview for screening blood donors for risk of HIV transmission. , 1990, JAMA.

[23]  L. Petersen,et al.  Human immunodeficiency virus type 1‐infected blood donors: behavioral characteristics and reasons for donation. , 1991, Transfusion.

[24]  J. Mosley.  Who should be our blood donors? , 1991, Transfusion.

[25]  J. Ward,et al.  Human immunodeficiency virus type 1 ‐infected blood donors:behavioral characteristics and reasons for donation , 1991, Transfusion.

[26]  B. Grossman,et al.  Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica , 1991, Transfusion.

[27]  A. M. Rose,et al.  Screening potential blood donors at risk for human immunodeficiency virus , 1991, Transfusion.

[28]  J. Kolins,et al.  Creating a uniform donor medical history questionnaire , 1991, Transfusion.

[29]  R. Gutierrez,et al.  Detection of antibodies to hepatitis C virus in U.S. blood donors , 1991, Journal of clinical microbiology.

[30]  H. Sheppard,et al.  An evaluation of the polymerase chain reaction in HIV-1 seronegative men. , 1991, Journal of acquired immune deficiency syndromes.

[31]  D. Brettler,et al.  The prevalence of antibody to HTLV‐I/II in United States plasma donors and in United States and French hemophiliacs , 1990, Transfusion.

[32]  Y. Hsueh,et al.  A study of confidential unit exclusion , 1990, Transfusion.

[33]  J. Macpherson,et al.  Markers for transfusion-transmitted disease in different groups of blood donors. , 1989, JAMA.

[34]  G. R. Carter,et al.  Efficacy of various methods of confidential unit exclusion in identifying potentially infectious blood donations , 1989, Transfusion.

[35]  P D Cumming,et al.  Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative. , 1989, The New England journal of medicine.

[36]  H. Klein,et al.  Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors. , 1989, The New England journal of medicine.

[37]  E. Schiff,et al.  Epidemiologic background of blood donors with antibody to human T‐cell lymphotropic virus , 1989, Transfusion.

[38]  G. Leparc,et al.  Impact of explicit questions about high‐risk activities on donor attitudes and donor deferral patterns. Results in two community blood centers , 1989, Transfusion.

[39]  J. Chiavetta,et al.  Donor self‐exclusion patterns and human immunodeficiency virus antibody test results over a twelve‐month period , 1989, Transfusion.

[40]  B. Ransil,et al.  Autologous versus homologous donors , 1988, Transfusion.

[41]  Dennis M. Smith,et al.  Current scientific/ethical dilemmas in blood banking , 1987 .

[42]  Floyd J. Fowler,et al.  Survey Research Methods , 1984 .

[43]  L. Bruce-Chwatt.  Infection, immunity, and blood transfusion. , 1984, British medical journal.

[44]  H. Krebs,et al.  Which criteria must be fulfilled for a donation or a donor to be considered 'voluntary'? , 1978, Vox sanguinis.